Sionna Therapeutics Cash Flow Statement (2024-2026) | SION

Cash Flow Statement Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -12.02M-8.73M-25.63M-16.01M-16.66M-18.24M-20.35M-20.44M-26.78M
Depreciation and Depletion (Quarter) 0.20M0.20M0.20M0.20M0.20M0.10M0.10M0.15M0.15M
Share-based Compensation (Quarter) 0.65M0.97M1.03M1.06M2.09M2.84M3.31M3.83M6.55M
Cash from Operations (Quarter) -13.18M-10.14M-17.69M-11.78M-16.29M-18.15M-15.23M-16.63M-21.84M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.49M0.72M1.00M0.79M0.70M1.17M-0.39M0.49M0.20M
Depreciation & Amortization (CF) (Quarter) 0.20M0.20M0.20M0.20M0.20M0.10M0.10M0.15M0.15M
Change in Working Capital
Change in Account Payables (Quarter) 1.67M-0.53M-1.76M1.08M3.55M-3.83M0.57M-0.71M1.21M
Change in Accured Expenses (Quarter) -2.62M-0.87M1.39M3.17M-4.32M2.12M1.68M2.49M-3.46M
Investing Activities
Capital Expenditures (Quarter) 0.03M0.09M0.09M0.20M
Change in Acquisitions & Divestments (Quarter) 33.50M22.45M30.49M33.17M77.33M65.67M50.15M
Cash from Investing Activities (Quarter) -123.93M-28.62M10.41M15.23M-141.19M-23.25M23.10M22.59M24.82M
Financing Activities
Other financing activities (Quarter) 0.50M1.43M0.32M
Change in Capital Stock
Shares Issued (Quarter) 0.12M0.03M202.39M-0.32M-200.09M200.09M
Preferred Shares Issued (Quarter) 181.33M
Misc.
Cash from Financing Activities (Quarter) 181.33M0.04M-1.00M-1.41M202.39M-0.31M1.97M1.66M1.89M
Change in Cash (Quarter) 44.23M-38.73M-8.28M2.04M44.91M-41.71M9.85M7.62M4.87M
Free Cash Flow (Quarter) -13.18M-10.14M-17.69M-11.81M-16.37M-18.15M-15.32M-16.83M-21.84M
Net Cash Flow (Quarter) 44.23M-38.73M-8.28M2.04M44.91M-41.71M9.85M7.62M4.87M